The U.S. Commerce Department is rolling out new export controls on biotechnology equipment and related technology amid national security concerns linked to AI and data science, Reuters’ David Shepardson reports. The department has raised concerns that China could utilize U.S. technology to bolster military capabilities and help create new weapons using AI, the author notes. Publicly traded companies that could be affected by this news include Bruker (BRKR), Waters (WAT), and Thermo Fisher (TMO).
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- Bruker Shares Limited Information Under SEC Regulations
- Bruker sees Q4 revenue $970M-$980M, consensus $962.89M
- Bruker ‘respectfully disagrees’ with District Court, to seek stay of injunction
- 10x Genomics secures permanent injunction in Bruker patent infringement lawsuit
- Court grants 10x Genomics’ motion in part in patent suit against NanoString